> The FTC has asked for more information about Genentech's proposed merger with Tanox. Report
> Japan has confirmed the third outbreak of avian flu in poultry. Report
> The head of ArQule's scientific advisory board will become the CEO of the newly-established Boston Biomedical. BBI will conduct scientific research under an eight-month contract with ArQule that will include a number of in vivo and in vitro studies, reports and publications related to mechanisms of action and biomarkers for ArQule's lead products, which are in human clinical trials. Release
> OncoGenex has priced its IPO of 4.5 million shares at $10 to $12 each. Report
> The FDA has approved Berlex's YAZ to treat moderate acne in women who want to use an oral contraceptive for birth control. Release
> Beijing Med-Pharm has acquired a stake in Guangzhou Pharmaceuticals, China's third-largest drug wholesaler. Release
And Finally… Researchers say that hard work and simple living have made one small town in Italy one of the healthiest places on the planet. Report